Rosefinch Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 12 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -9.51%
- Profit Growth 7.21%
- Ebitda 14.68%
- Net Worth 8.82%
- Total Assets 0.44%
About Rosefinch Lifesciences
Rosefinch Lifesciences Private Limited (RLPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 June 2012 and has a history of 12 years and eight months. Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Chiragbhai Paleja, Milankumar Trivedi, and Aditya Bhatt serve as directors at the Company.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24233GJ2012PTC070746
-
Company No.
070746
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
14 Jun 2012
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Rosefinch Lifesciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chiragbhai Paleja
|
Director | 14-Jun-2012 | Current |
|
Milankumar Trivedi
|
Director | 14-Jun-2012 | Current |
|
Aditya Bhatt
|
Director | 26-Dec-2017 | Current |
Financial Performance of Rosefinch Lifesciences.
Rosefinch Lifesciences Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 9.51% decrease. The company also saw a slight improvement in profitability, with a 7.21% increase in profit. The company's net worth moved up by a moderate rise of 8.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rosefinch Lifesciences?
In 2023, Rosefinch Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Rosefinch Pharmaceutique Private LimitedChiragbhai Paleja, Milankumar Trivedi and 1 more are mutual person
-
Rosefinch Advisors Private LimitedChiragbhai Paleja, Milankumar Trivedi and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rosefinch Lifesciences?
Unlock and access historical data on people associated with Rosefinch Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rosefinch Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rosefinch Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
